Shortened first-line TB treatment in Brazil: potential cost savings for patients and health services
Authors:
- Anete TrajmanATAnete Trajman
- Mayara Lisboa BastosMBMayara Lisboa Bastos
- Marcia BeloMBMarcia Belo
- Janaína CalaçaJCJanaína Calaça
- Júlia GasparJGJúlia Gaspar
- Alexandre Martins dos SantosASAlexandre Martins dos Santos
- Camila Martins dos SantosCSCamila Martins dos Santos
- Raquel Trindade BritoRBRaquel Trindade Brito
- William A. WellsWWWilliam A. Wells
- Frank G. CobelensFCFrank G. Cobelens
- Anna VassallAVAnna Vassall
- Gabriela B. GomezGGGabriela B. Gomez
Open Access
- 1 December 2015
- journal article
- research article
- Published by Springer Nature in BMC Health Services Research
- Vol. 16 (1) , 27
Abstract
Shortened treatment regimens for tuberculosis are under development to improve treatment outcomes and reduce costs. We estimated potential savings from a societal perspective in Brazil following the introduction of a hypothetical four-month regimen for tuberculosis treatment. Data were gathered in ten randomly selected health facilities in Rio de Janeiro. Health service costs were estimated using an ingredient approach. Patient costs were estimated from a questionnaire administered to 126 patients. Costs per visits and per case treated were analysed according to the type of therapy: self-administered treatment (SAT), community- and facility-directly observed treatment (community-DOT, facility-DOT). During the last 2 months of treatment, the largest savings could be expected for community-DOT; on average USD 17,351-18,203 and USD 43,660-45,856 (bottom-up and top-down estimates) per clinic. Savings to patients could also be expected as the median (interquartile range) patient-related costs during the two last months were USD 108 (13–291), USD 93 (36–239) and USD 11 (7–126), respectively for SAT, facility-DOT and community-DOT. Introducing a four-month regimen may result in significant cost savings for both the health service and patients, especially the poorest. In particular, a community-DOT strategy, including treatment at home, could maximise health services savings while limiting patient costs. Our cost estimates are likely to be conservative because a 4-month regimen could hypothetically increase the proportion of patients cured by reducing the number of patients defaulting and we did not include the possible cost benefits from the subsequent prevention of costs due to downstream transmission averted and rapid clinical improvement with less side effects in the last two months.Keywords
This publication has 28 references indexed in Scilit:
- The High Cost of Free Tuberculosis Services: Patient and Household Costs Associated with Tuberculosis Care in Ebonyi State, NigeriaPLOS ONE, 2013
- Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa – a systematic reviewBMC Public Health, 2012
- Patient medical costs for tuberculosis treatment and impact on adherence in China: a systematic reviewBMC Public Health, 2011
- Assessing access barriers to tuberculosis care with the Tool to Estimate Patients' Costs: pilot results from two districts in KenyaBMC Public Health, 2011
- Patients' Costs and Cost-Effectiveness of Tuberculosis Treatment in DOTS and Non-DOTS Facilities in Rio de Janeiro, BrazilPLOS ONE, 2010
- GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysisEuropean Respiratory Journal, 2008
- Directly observed therapy for treating tuberculosis2007
- Peculiaridades do controle da tuberculose em um cenário de violência urbana de uma comunidade carente do Rio de JaneiroJornal Brasileiro de Pneumologia, 2007
- Análise do Programa de Controle da Tuberculose em Cáceres, Mato Grosso, antes e depois da implantação do Programa de Saúde da FamíliaJornal Brasileiro de Pneumologia, 2007
- Tuberculose em Salvador: custos para o sistema de saúde e para as famíliasRevista de Saúde Pública, 2005